Quantum BioPharma Ltd.
QNTM
$3.02
-$0.34-9.99%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 43.10% | 42.52% | -7.89% | -60.00% | -40.06% |
| Total Depreciation and Amortization | -10.94% | 2.76% | 9.02% | 14.98% | -6.62% |
| Total Amortization of Deferred Charges | -- | -100.00% | -- | -- | -- |
| Total Other Non-Cash Items | 46.81% | -80.44% | 73.11% | 231.90% | -693.78% |
| Change in Net Operating Assets | -69.40% | 296.87% | -480.93% | -96.14% | 1,092.19% |
| Cash from Operations | 82.25% | 11.68% | 54.26% | -409.79% | 75.85% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -14.13% | 130.00% | -0.82% | -208.55% | 135.91% |
| Cash from Investing | -14.13% | 130.00% | -0.82% | -208.55% | 135.91% |
| Total Debt Issued | -95.91% | -86.16% | -36.90% | 207.46% | 434.15% |
| Total Debt Repaid | -7,340.20% | 98.75% | -3,415.45% | 21.81% | -547.83% |
| Issuance of Common Stock | -- | -100.00% | 217.86% | -96.91% | -78.92% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 441.09% | -79.73% | -58.84% | 26.99% | -63.38% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 238.78% | 47.96% | 18.44% | -186.16% | 1,642.70% |